Pioglitazone

Hmm… We’d better think about this again. Pioglitazone is not a good first‑line choice because it causes weight gain and fluid retention and it lacks clear cardiovascular outcome benefits. If a thiazolidinedione is considered at all, it is considered in cases where first line drugs are not indicated or unavailable, or in combination with other first line drugs.

Try to think about other drugs with favourable weight and cardiovascular profiles. Always consider the full clinical context when prescribing medications and try again!

  • Ξεκινήστε βυθίζοντας την πιπέτα μέσα στο υγρό που σκοπεύετε να αναρροφήσετε [undo]
  • MAC [undo]
  • LB [undo]
  • Continue to consider the movement of water [undo]
  • EMB [undo]
  • Έλεγχος για κακοήθεια, φυματίωση και ηπατίτιδες επανέλεγχος λευκωματουρίας και νεφρικής λειτουργίας [undo]
  • Έναρξη ανοσοκατασταλτικής αγωγής [undo]
  • Cultural Bridging / Critical Path [undo]
  • Trăsături [undo]
  • Preparation of liquid cultures [undo]
  • Permanently stop taking metformin [undo]
  • Ζητώ καρυότυπο [undo]
  • Decision Point [undo]
  • Heart rate [undo]
  • Sacubitril-valsartan (ARNI) [undo]
  • Χαρακτηριστικά [undo]
  • EMB [undo]
  • Tell the patient to change devices without giving proper guidance. [undo]
  • Răspunsul 2 [undo]
  • Start a therapy [undo]
  • Option 2 [undo]
  • Lab coat may transfer hazardous materials to the outside general area and contaminate the area [undo]
  • Ask local cadre to help [undo]
  • recovery is going take time, but still can be achieved with routine physiotherapy [undo]
  • To avoid our Professor telling us off [undo]
  • Further Developments [undo]
  • Διπλοειδές και Απλοειδές [undo]
  • Μετά από τη διάγνωση [undo]
  • US examination [undo]
  • Pioglitazone [undo]

Map: Michael Green_GEMD_2 (1116)
Node: 21115
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway